4//SEC Filing
Derakhshan Behrad 4
Accession 0001562180-24-006259
CIK 0001710072other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:14 PM ET
Size
8.0 KB
Accession
0001562180-24-006259
Insider Transaction Report
Form 4
Derakhshan Behrad
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-12+138,750→ 138,750 totalExercise: $17.05Exp: 2034-08-12→ Common Stock (138,750 underlying) - Award
Restricted Stock Units
2024-08-12+23,125→ 23,125 totalExercise: $0.00Exp: 2034-08-12→ Common Stock (23,125 underlying)
Footnotes (2)
- [F1]1/48th of the shares subject to the option vest each month beginning on August 12, 2024, subject to the Reporting Person continuing as a service provider through each vest date.
- [F2]Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2024.
Documents
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0001853109
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:14 PM ET
- Size
- 8.0 KB